HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Loris De Cecco Selected Research

Loris De Cecco Research Topics

Disease

53Neoplasms (Cancer)
11/2022 - 09/2004
21Breast Neoplasms (Breast Cancer)
01/2022 - 06/2005
11Ovarian Neoplasms (Ovarian Cancer)
03/2021 - 10/2004
11Squamous Cell Carcinoma of Head and Neck
01/2021 - 04/2015
5Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 04/2015
5Ovarian Epithelial Carcinoma
01/2022 - 07/2015
5Carcinoma (Carcinomatosis)
01/2020 - 03/2010
5Carcinogenesis
12/2019 - 10/2004
3Melanoma (Melanoma, Malignant)
11/2022 - 06/2004
3Disease Progression
11/2022 - 12/2017
3Glioma (Gliomas)
06/2022 - 06/2014
3Hypoxia (Hypoxemia)
01/2022 - 04/2015
3Squamous Cell Neoplasms (Squamous Cell Cancer)
12/2019 - 01/2016
2Infections
03/2021 - 01/2021
2Neoplasm Metastasis (Metastasis)
04/2020 - 01/2017
2Adenocarcinoma of Lung
10/2019 - 06/2009
2Sarcoma (Soft Tissue Sarcoma)
11/2018 - 01/2017
2Colonic Neoplasms (Colon Cancer)
01/2016 - 01/2012
2Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 01/2013
1Circulating Neoplastic Cells
01/2022
1Triple Negative Breast Neoplasms
01/2022
1Breast Diseases (Breast Disease)
08/2021
1Rheumatoid Arthritis
06/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2021
1Pathologic Complete Response
01/2021
1Progressive Multifocal Leukoencephalopathy
01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
01/2021
1Virus Diseases (Viral Diseases)
01/2021
1Diarrhea
01/2021
1Papillary Thyroid Cancer
11/2020
1Lymphatic Metastasis
11/2020
1Multiple Myeloma
10/2020

Drug/Important Bio-Agent (IBA)

25MicroRNAs (MicroRNA)IBA
01/2022 - 03/2010
10Biomarkers (Surrogate Marker)IBA
04/2021 - 11/2009
9Biological ProductsIBA
06/2022 - 10/2004
8Estrogen ReceptorsIBA
01/2020 - 06/2005
7Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2014
5RNA (Ribonucleic Acid)IBA
01/2022 - 06/2004
5Cetuximab (Erbitux)FDA Link
12/2019 - 01/2016
5PlatinumIBA
12/2019 - 01/2013
4Trastuzumab (Herceptin)FDA Link
01/2022 - 09/2015
4Pharmaceutical PreparationsIBA
01/2021 - 01/2016
4Complementary DNA (cDNA)IBA
06/2008 - 06/2004
3Phenobarbital (Luminal)FDA Link
01/2020 - 07/2015
3Urethane (Ethyl Carbamate)IBA
11/2017 - 04/2014
3Messenger RNA (mRNA)IBA
01/2017 - 01/2015
3Cisplatin (Platino)FDA LinkGeneric
07/2015 - 10/2011
3DNA (Deoxyribonucleic Acid)IBA
01/2013 - 10/2011
3CPG-oligonucleotideIBA
01/2013 - 10/2011
2VemurafenibIBA
11/2022 - 01/2016
2dipinacoline glutamateIBA
06/2022 - 06/2014
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2020 - 07/2015
2Long Noncoding RNAIBA
01/2020 - 01/2017
2Vinorelbine (Navelbine)FDA LinkGeneric
07/2018 - 06/2014
2nimotuzumabIBA
07/2018 - 06/2014
2Type 4 Fibroblast Growth Factor ReceptorIBA
06/2009 - 10/2004
2Estrogen Receptor Modulators (Antiestrogen)IBA
10/2008 - 06/2005
1Drug CombinationsIBA
11/2022
1Mechanistic Target of Rapamycin Complex 1IBA
11/2022
1dabrafenibIBA
11/2022
1trametinibIBA
11/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2022
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
11/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2022
1Complement System Proteins (Complement)IBA
12/2021
1pristane (pristan)IBA
06/2021
1Viral RNAIBA
03/2021
1COVID-19 VaccinesIBA
03/2021
1Methionine (L-Methionine)FDA Link
01/2021
1Choline KinaseIBA
01/2021
1Choline (Choline Chloride)IBA
01/2021
1LigandsIBA
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2021
1Vasopressins (Vasopressin)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1InterferonsIBA
01/2021
1NivolumabIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Granzymes (Granzyme)IBA
01/2021
1Alkylating AgentsIBA
10/2020
1Proteasome InhibitorsIBA
10/2020
1Immunomodulating AgentsIBA
10/2020
1Tumor Biomarkers (Tumor Markers)IBA
04/2020
1Untranslated RNA (Noncoding RNA)IBA
01/2020
1Formaldehyde (Formol)FDA Link
01/2020
1ParaffinIBA
01/2020
1Piwi-Interacting RNAIBA
01/2020
1matrigelIBA
01/2020
1Transforming Growth Factor beta (TGF-beta)IBA
01/2020
1SmokeIBA
10/2019

Therapy/Procedure

19Therapeutics
11/2022 - 10/2008
10Drug Therapy (Chemotherapy)
10/2020 - 10/2011
4Neoadjuvant Therapy
01/2022 - 01/2021
2Aftercare (After-Treatment)
01/2022 - 01/2021
2Immunotherapy
01/2021 - 01/2017
2Re-Irradiation
07/2018 - 06/2014
1Salvage Therapy
01/2022
1Injections
01/2021
1Immunomodulation
01/2021